Federation des caisses Desjardins du Quebec’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,630
Closed -$4.91K 2632
2021
Q3
$4.91K Hold
1,630
﹤0.01% 2239
2021
Q2
$6.37K Hold
1,630
﹤0.01% 2174
2021
Q1
$8.26K Hold
1,630
﹤0.01% 2053
2020
Q4
$6.67K Buy
+1,630
New +$8.01K ﹤0.01% 2002
2020
Q2
Sell
-26,297
Closed -$87.3K 2303
2020
Q1
$87.3K Hold
26,297
﹤0.01% 1087
2019
Q4
$119K Hold
26,297
﹤0.01% 1254
2019
Q3
$109K Hold
26,297
﹤0.01% 1273
2019
Q2
$99.5K Hold
26,297
﹤0.01% 1296
2019
Q1
$110K Hold
26,297
﹤0.01% 1133
2018
Q4
$65.6K Hold
26,297
﹤0.01% 1227
2018
Q3
$192K Hold
26,297
﹤0.01% 1031
2018
Q2
$97.5K Hold
26,297
﹤0.01% 1195
2018
Q1
$101K Hold
26,297
﹤0.01% 1168
2017
Q4
$94.4K Hold
26,297
﹤0.01% 1182
2017
Q3
$104K Hold
26,297
﹤0.01% 1149
2017
Q2
$134K Hold
26,297
﹤0.01% 1122
2017
Q1
$181K Buy
+26,297
New +$205K ﹤0.01% 925

Other funds holding AGTC

Federation des caisses Desjardins du Quebec's AGTC Position: Q4 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 1,630 shares — an estimated $4.91K sold.

Federation des caisses Desjardins du Quebec first reported a position in AGTC in Q1 2017 and held it in 17 quarters. The position peaked at $192K in Q3 2018. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • Federation des caisses Desjardins du Quebec reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 1,630 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $4.91K.
  • Federation des caisses Desjardins du Quebec first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 17 quarters.
  • Federation des caisses Desjardins du Quebec's Applied Genetic Technologies Corporation position peaked at $192K in Q3 2018.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2021, filed 30 Aug 2024.